Literature DB >> 18179748

Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.

M P Foschino Barbaro1, G E Carpagnano, A Spanevello, M G Cagnazzo, P J Barnes.   

Abstract

Chronic obstructive pulmonary diseases (COPD) is a pulmonary disease characterized by systemic abnormalities. The aim of this study is to investigate inflammation and systemic effects in mild COPD. Twenty-seven mild stable smoking related COPD patients and 15 age-matched healthy subjects were enrolled in the study. IL-6, TNF-alpha and IL-4 in plasma, sputum and exhaled breath condensate were measured. We also measured exhaled nitric oxide (NO) and pH in sputum and in breath condensate. Moreover, fat-free mass, body mass index (BMI), respiratory muscle strength, plasma oxidative stress and C-reactive protein (CRP) were measured. Higher concentrations were found of CRP, of diacron reactive oxygen metabolites (DROMs) and of IL-6, TNF-alpha and IL-4 either in plasma or in supernatant of induced sputum or in exhaled breath condensate of COPD subjects compared to healthy controls. Furthermore, higher concentrations were observed of exhaled NO and lower exhaled pH in breath condensate of COPD when compared with healthy subjects. In the group of COPD patients, the subjects with airway reversibility showed an increase of sputum eosinophils and exhaled NO, whereas the subjects without airway obstruction reversibility showed an increase in sputum neutrophils, TNF-alpha and IL-6. We also found a trend towards a decrease in fat-free mass and respiratory muscle strength in COPD compared to healthy subjects and a negative correlation between these systemic indices (fat-free mass, maximal inspiratory pressure, maximal expiratory pressure) and TNF-alpha concentrations in the blood, sputum and breath condensate. We conclude that mild COPD subjects present an increase in inflammatory markers in blood and in airways of similar pattern and furthermore, the neutrophilic pattern of airway inflammation observed in the group of COPD subjects without an airway obstruction reversibility makes it more likely that systemic features are present.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18179748     DOI: 10.1177/039463200702000411

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  23 in total

1.  Role of vasoactive intestinal peptide in hyperoxia-induced injury of primary type II alveolar epithelial cells.

Authors:  Xiaoxiao Ao; Fang Fang; Feng Xu
Journal:  Indian J Pediatr       Date:  2010-10-07       Impact factor: 1.967

Review 2.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

3.  Basis for sensitive and selective time-delayed luminescence detection of hydroxyl radical by lanthanide complexes.

Authors:  Katie L Peterson; Maximilian J Margherio; Phi Doan; Kyle T Wilke; Valérie C Pierre
Journal:  Inorg Chem       Date:  2013-07-26       Impact factor: 5.165

4.  Effect of modified Total Body Recumbent Stepper training on exercise capacity and thioredoxin in COPD: a randomized clinical trial.

Authors:  Wentao Duan; Dan Zeng; Jin Huang; Jing Gu; San Li; Wei Zhou; Jinling Ma; Yan Jiang; Liming Zhu; Xudong Xiang; Aiguo Dai
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

5.  Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4.

Authors:  M L Castellani; P Conti; M Felaco; J Vecchiet; C Ciampoli; G Cerulli; P Boscolo; T C Theoharides
Journal:  Neurotox Res       Date:  2009-02-18       Impact factor: 3.911

6.  Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.

Authors:  Timothy M Bahr; Grant J Hughes; Michael Armstrong; Rick Reisdorph; Christopher D Coldren; Michael G Edwards; Christina Schnell; Ross Kedl; Daniel J LaFlamme; Nichole Reisdorph; Katerina J Kechris; Russell P Bowler
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

7.  Neuropeptide substance P attenuates hyperoxia-induced oxidative stress injury in type II alveolar epithelial cells via suppressing the activation of JNK pathway.

Authors:  Bo Huang; Hongmin Fu; Ming Yang; Fang Fang; Fengwu Kuang; Feng Xu
Journal:  Lung       Date:  2009-09-30       Impact factor: 2.584

8.  TNF-α is associated with loss of lean body mass only in already cachectic COPD patients.

Authors:  Tomas M L Eagan; Esteban C Gabazza; Corina D'Alessandro-Gabazza; Paloma Gil-Bernabe; Shinya Aoki; Jon A Hardie; Per S Bakke; Peter D Wagner
Journal:  Respir Res       Date:  2012-06-18

9.  Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study.

Authors:  Olof Birna Margretardottir; Sigurdur James Thorleifsson; Gunnar Gudmundsson; Isleifur Olafsson; Bryndis Benediktsdottir; Christer Janson; A Sonia Buist; Thorarinn Gislason
Journal:  COPD       Date:  2009-08       Impact factor: 2.409

10.  The overlap phenotype: the (missing) link between asthma and COPD.

Authors:  Barbara Piras; Marc Miravitlles
Journal:  Multidiscip Respir Med       Date:  2012-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.